LONDON--(BUSINESS WIRE)--According to the latest market study released by Technavio, the global veterinary clostridium vaccine market is expected to grow at a CAGR of almost 5% during the forecast period.
This research report titled ‘Global Veterinary Clostridium Vaccine Market 2017-2021’ provides an in-depth analysis of the market in terms of revenue and emerging market trends. This market research report also includes up to date analysis and forecasts for various market segments and all geographical regions.
The global veterinary clostridium vaccine market is expected to be benefitted from the growing concern over food safety, as dependency on livestock products like meat, milk, and other products is increasing. The mortality rate associated with infection transmission from animals to humans through these products is alarming. This has led to the increasing awareness among livestock product suppliers along with continuous government initiatives. All these factors have driven the vendors to invest in research and development (R&D) to improve and expand product portfolio, thereby driving the market growth.
This report is available at a USD 1,000 discount for a limited time only: View market snapshot before purchasing
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Technavio’s healthcare and life science research analysts categorize the global veterinary clostridium vaccine market into the following segments by species type. They are:
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report including the market size and forecast, drivers, challenges, trends, and more.
The top three species type segments for the global veterinary clostridium vaccines market are discussed below:
Swine is the largely affected animal species by various diseases caused due to clostridial species. Three species that affect the swine animals the most are Clostridium perfringens type A, Clostridium perfringens type C, and Clostridium difficile. C. perfringens type C is associated with newborn piglets. These piglets show clinical symptoms such as diarrhea due to microbes of C. perfringens type C and the mortality rate due to this is very high. The cause of diarrhea due to this species is well known from the decades.
According to Sapna Jha, a lead infectious and rare disease research analyst from Technavio, “In 2016, the global Clostridium swine vaccine market contributed around 29 % of the global veterinary Clostridium vaccine market. The market is growing substantially because of the increased mortality rate due to infection caused by various clostridial species.”
These clostridial diseases are associated with very poor prognosis, and the first sign of illness may be death. Moreover, the success rate of treatment is rare in bovine animals; hence, better preventive measures can avoid the spread of these diseases. The vaccination plays a key role in preventing these diseases, which, in turn, prevents loss of productivity and monetary loss.
“The other factor which is fueling the market is the high dependency on livestock products from bovine animals. Considering the growing dependency on these products, the need for food safety should be improved. These vaccinations make them disease-free and more productive to meet the current demand,” adds Sapna.
The poultry animals get affected by C. perfringens, which causes clostridial enteritis. The disease is associated with abrupt intestinal health in broiler flocks. The common symptom associated with this disease is growth retardation. This is observed in the third week, as the impaired intestinal health is observed in the third week and can be easily recognized by the farmers and veterinarians.
The consumption of poultry meat is also increasing globally, due to the increase in per capita income and growing population. Thus, the vaccination is a key aspect of maintaining food safety, which helps to avoid loss of lives and provides better products to meet the demands.
The top vendors highlighted by Technavio’s research analysts in this report are:
- Merial (now part of Boehringer Ingelheim)
Browse Related Reports:
- Global Clostridium Difficile Treatment Market 2017-2021
- Global Scleroderma Treatment Market 2017-2021
- Global Retinal Drugs Market 2017-2021
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at firstname.lastname@example.org.